Laboratory Corp. of America Holdings (LH)
-NYSE 98.97 
1.29(1.32%) May 17, 4:02PM EDT
| Prev Close: | 97.68 |
|---|
| Open: | 97.87 |
|---|
| Bid: | 96.30 x 100 |
|---|
| Ask: | 101.76 x 100 |
|---|
| 1y Target Est: | 98.31 |
|---|
| Beta: | 0.71 |
|---|
| Next Earnings Date: | 19-Jul-13 |
|---|
| Day's Range: | 97.69 - 99.11 |
|---|
| 52wk Range: | 81.56 - 99.11 |
|---|
| Volume: | 1,668,715 |
|---|
| Avg Vol (3m): | 826,914 |
|---|
| Market Cap: | 9.19B |
|---|
| P/E (ttm): | 16.73 |
|---|
| EPS (ttm): | 5.92 |
|---|
| Div & Yield: | N/A (N/A) |
|---|
The broker you select will become the default broker for Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- Laboratory Corporation Of America Holdings (LH): Today's Featured Health Care Winnerat TheStreet(Thu, May 16)
- Laboratory Corporation Of America Reaches New 52-Week High (LH)at TheStreet(Wed, May 15)
- LABORATORY CORP OF AMERICA HOLDINGS Files SEC form 8-K, Regulation FD DisclosureEDGAR Online(Tue, May 14)
- LABORATORY CORP OF AMERICA HOLDINGS Files SEC form 8-K, Submission of Matters to a Vote of Security HoldersEDGAR Online(Fri, May 10)
- [$$] Quest for Profitsat Barrons.com(Thu, May 9)
- LABORATORY CORP OF AMERICA HOLDINGS Files SEC form 8-K, Regulation FD DisclosureEDGAR Online(Wed, May 8)
- LabCorp is Scheduled to Present at the Bank of America Merrill Lynch 2013 Health Care ConferenceBusiness Wire(Wed, May 8)
- Laboratory Corp. of America Holdings - Shareholder/Analyst Callat Seeking Alpha(Wed, May 8)
- LABORATORY CORP OF AMERICA HOLDINGS Files SEC form 8-K, Regulation FD DisclosureEDGAR Online(Tue, May 7)
- LABORATORY CORP OF AMERICA HOLDINGS FinancialsEDGAR Online Financials(Tue, May 7)
- LABORATORY CORP OF AMERICA HOLDINGS Files SEC form 8-K, Regulation FD DisclosureEDGAR Online(Thu, May 2)
- LabCorp to Webcast Its Annual Meeting of StockholdersBusiness Wire(Thu, May 2)
- LABORATORY CORP OF AMERICA HOLDINGS Files SEC form 10-Q, Quarterly ReportEDGAR Online(Wed, May 1)
- Qiagen Acquires IngenuitySystemsZacks(Tue, Apr 30)
- Opportunities in Hepatitis C and Genomic Technologies: A Wall Street Transcript Interview with David Ferreiro, Executive Director and Senior Analyst at Oppenheimer & Co. Inc.Wall Street Transcript(Fri, Apr 26)
Key Statistics
| Forward P/E (1 yr): | 12.92 |
|---|
| P/S (ttm): | 1.60 |
|---|
| Ex-Dividend Date: | 29-Mar-94 |
|---|
Analysts
| Annual EPS Est
(Dec-13)
: | 7.11 |
|---|
| Quarterly EPS Est
(Jun-13)
: | 1.80 |
|---|
| Mean Recommendation*: | 2.9 |
|---|
| PEG Ratio (5 yr expected): | 1.36 |
|---|
Business Summary
Laboratory Corporation of America Holdings operates as an independent clinical laboratory company worldwide. It offers a range of clinical laboratory tests, including blood chemistry analyses, urinalyses, blood cell counts, thyroid tests, Pap test...
View More